Home
 
About NEAVS
 
ESEC
Science Education
 
Better Science
 
Cruelty-Free Living
 
Programs
& Campaigns
 
Resources
& Archives
 
Helping & Giving
 
Contact Us
 
Shop NEAVS
 
Links
 
Site Map
 Science Everyone Can Live With

 

 

Better Science

Alternatives to Vivisection:
Non-Animal Methods in Biomedical Research

Epidemiological Studies
  • Epidemiology is the study of health characteristics in human populations and the application of this study to the control of health problems. (1)
  • The Framingham heart study, initiated in 1948 with 5, 209 original participants, monitors the city's population and established a link between heart disease and risk factors, such as elevated cholesterol levels and high blood pressure. (2)
  • Epidemiological studies revealed that smoking is associated with lung cancer. (3)
  • AIDS was first identified in epidemiological studies when rare infections and malignancies began showing up in patients in the late 1970's. (4)
Clinical Studies
  • Carefully managed clinical trials provide information about human health and disease. (5)
  • Clinical studies have shown that lowering cholesterol levels with drugs, diet or both greatly reduces subsequent heart attacks and stroke. (6)
  • Drugs for treating AIDS and HIV infection, including AZT, were identified in clinical trials or in in vitro (test tube) studies. (7)
Autopsies and Post-Mortem Studies
  • Human autopsy is the examination, after death, of the tissues and organs of the human body to determine cause of death or existence of pathological conditions. (8)
  • Autopsy research has been responsible for the discovery and description of thousands of diseases, including Legionnaire's disease, viral hepatitis, aplastic anemia and fetal alcohol syndrome. (9)
  • Autopsies can be especially useful in studying environmental and occupational diseases, cancer, heart disease, neurological disorders, AIDS, Sudden Infant Death Syndrome and aging. (10)
Post-Marketing Surveillance
  • Using computer technology, detailed and comprehensive records can be collected and maintained on the side-effects of drugs. This information, if stored in a central database, would enable rapid identification of dangerous drugs. (11)
  • Unexpected beneficial side-effects of drugs can also be recognized in post-marketing surveillance. (12)
  • The anti-cancer properties of nitrogen mustard and actinomycin D and the mood-elevating effects of tricyclic antidepressants were all discovered through clinical observation of side-effects. (13)
Non-Invasive Imaging Techniques
  • Non-invasive imaging techniques, such as CAT, MRI, PET and SPECT can reveal how the human body works and can monitor the progress of disease and response to therapy. (14)
  • CAT scans use computers to reconstruct three-dimensional images of the body from X-rays. (15)
  • MRI (Magnetic Resonance Imaging) has allowed investigators to make functional maps of the human brain and evaluate patients with epilepsy. (16)
  • MRI can also monitor changes in blood flow and may reveal new insights into the mechanism of stroke. (17)
  • PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computerized Tomography) use compounds that have been tagged with isotopes and measure how these interact with the human body. (18)
  • PET using tagged cocaine has been used to study drug addiction, by revealing where cocaine binds in the human brain. (19)
  • PET and SPECT have also been used to study Alzheimer's, Parkinson's and Huntington's disease, cerebrovascular disease and psychiatric disorders. (20)
Tissue and Cell Culture
  • Cells or tissues can be obtained from human volunteers, surgical operations, biopsies and post- mortem specimens, cultured in the laboratory and used for in vitro (test tube) studies. (21)
  • Some cells can be immortalized to form cell lines that provide a constant supply of identical test material. (22)
  • The National Cancer Institute (NCI) switched from screening potential anti-cancer drugs on leukemic mice to a battery of human cancer cell lines. The cell lines are cheaper, more reliable and provide information directly applicable to humans. (23)
  • AIDS drugs can be screened in vitro by determining whether they block the virus' ability to kill human T-cells.(24)
  • Diseased human tissue can be used for study and to evaluate drug therapies; for example, researchers in Germany study heart disease by using diseased human heart muscle preparations. (25)
  • Placental tissue, which is usually discarded after birth, is physiologically complex and can be used for pharmacological studies. (26) Microbiological Studies
  • Microorganisms, such as bacteria, are ideally suited for screening large numbers of toxins, mutagens and irritants. They reproduce rapidly and can be maintained at low cost. (27)
  • The Ames test uses salmonella bacteria to assess a chemical's potential for mutagenicity (its ability to alter a cell's hereditary information), which is one of the steps in the formation of cancer. (28)
Mathematical and Computer Models
  • Mathematical models use human clinical and epidemiological data to generate theories about complex disease processes; for example, a mathematical model has revealed that there are two distinct types of breast cancer, which require different therapies. (29)
  • How drugs work (their activity) is determined by their structure. New drugs can be designed using computers to evaluate structure-activity relationships. (30)
  • Computer models can simulate human disease states and allow physicians to try out new therapies and drugs. (31)
Chromatography and Spectroscopy
  • These are physical and chemical techniques that identify, isolate and measure compounds in drugs, toxins and bodily fluids, such as blood or urine. (32)
  • Physiochemical techniques have replaced the use of animals in assays for vitamins A, D and E (33) and can identify the amount of drugs taken in case of an overdose. (34)
  • Chromatographic techniques separate components of a mixture. (35)
  • Spectroscopy measures the energy absorbed or emitted from a compound when bombarded by an energy source and is used to identify the components of a mixture. (36)


 

References

  1. Kelsey, J. L. and Parker, S. "Epidemiology as an alternative to animal research." Non-Animal Techniques in Biomedical and Behavioral Research and Testing (M.B. Kapis and S.C. Gad, eds., Ann Arbor: Lewis Publishers, 1993) p. 165.
  2. Sytkowski, P. A., D'Agostino, R. B., Belanger, A. and Kannel, W. B. "Sex and time trends in cardiovascular disease incidence and mortality: The Framingham Heart Study, 1950-1989. American Journal of Epidemiology, Vol. 143, 1996, pp. 338-339.
  3. Kelsey, J. L. and Parker, S., p. 167.
  4. Kelsey, J. L. and Parker, S., p. 178.
  5. Stephens, M. L. Alternatives to Current Uses of Animals in Research, Safety Testing, and Education: A Layman's Guide (Washington, D.C.: The Humane Society of the United States,1986), p. 29.
  6. Bryne, K. P. Understanding and Managing Cholesterol: A Guide for Wellness Professionals (Champaign, IL: Human Kinetics Books, 1991), p. 5.
  7. Kelsey, J. L. and Parker, S., p. 179.
  8. Kapis, M. B. "Human autopsies in biomedical research." Non-Animal Techniques in Biomedical and Behavioral Research and Testing (M.B. Kapis and S.C. Gad, eds., Ann Arbor: Lewis Publishers, 1993), p. 195.
  9. Kapis, M. B., pp. 196-197.
  10. Kapis, M. B., p. 198.
  11. Kaufman, S. R., Cohen, M. J., Cramer, M. J., Contard, P. C., Hahner, K. and Todd, B. A Critical Look at Animal Experimentation (Medical Research Modernization Committee, 1995), p. 8.
  12. Kaufman et al., p. 8.
  13. Kaufman et al., p. 8.
  14. Morris, P. G. "Magnetic resonance and the use of animals." Non-Animal Techniques in Biomedical and Behavioral Research and Testing (M.B. Kapis and S.C. Gad, eds., Ann Arbor: Lewis Publishers, 1993), pp. 237-238.
  15. Allison, R. "How did we get here? Advances in Radiology." Physicians Committee for Responsible Medicine Update, Spring 1992, p. 6.
  16. Mazziotta, J. C. "Mapping human brain activity in vivo." Western Journal of Medicine, Vol.161, 1994, p. 276.
  17. Morris, P. G., p. 245.
  18. Mazziotta, J. C., p. 276.
  19. Maltz, G. "PET offers insight into the chemistry of cocaine addiction." Clinical Psychiatry News, September 1994, p. 8.
  20. Mazziotta, p. 276.
  21. Alternatives to Animal Use in Research, Testing, and Education. Office of Technology Assessment, Congress of the United States (New York: Marcel Dekker, Inc., 1988) p. 123.
  22. Sweetnam, P., Bauer, C. and Charlton, M. "In vitro techniques for use in drug discovery." Non-Animal Techniques in Biomedical and Behavioral Research and Testing (M.B. Kapis and S.C. Gad, eds., Ann Arbor: Lewis Publishers, 1993) p. 50.
  23. "Drug discovery screen adapts to changes." Journal of the National Cancer Institute, Vol. 82,1990, p. 1087.
  24. Rice, W. G. and Bader, J. P. "Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals." Advances in Pharmacology, Vol. 33, 1995, pp. 402-405.
  25. Schror, K. and Verhaggen, R. "Use of human post-mortem cerebral blood vessels to study vasospasm." Trends in Pharmacological Sciences, Vol. 9, 1988, p. 71.
  26. Stephens, M. L., p. 33.
  27. Alternatives to Animal Use in Research, p. 123.
  28. Alternatives to Animal Use in Research, pp. 187-188.
  29. Kaufman, et al., pp. 8-9.
  30. Rao, S. N. "Modeling drug-nucleic acid interactions: An exercise in computer graphics and computational chemistry." Nucleic Acid Target Drug Design (Propst, C. L. and Perun, T. J., eds., New York: Marcel Dekker, Inc., 1992) pp. 66, 88.
  31. Witten, M. "Computational modeling of biological/medical systems." Non-Animal Techniques in Biomedical and Behavioral Research and Testing (M.B. Kapis and S.C. Gad, eds., Ann Arbor: Lewis Publishers, 1993), p. 128.
  32. Kapis, M. B. "Physicochemical techniques in biological research and testing." Non-Animal Techniques in Biomedical and Behavioral Research and Testing (M.B. Kapis and S.C. Gad, eds., Ann Arbor: Lewis Publishers, 1993), p. 217.
  33. Strohecker, R. and Henning, H. M. Vitamin Assay - Tested Methods (Verlag Chemie, 1965) pp. 34, 271, 296-297.
  34. Seiler, H. G., Sigel, H. and Sigel, A. Handbook on Toxicity of Inorganic Compounds (New York: Marcel Dekker, Inc., 1988) p. 208.
  35. Kapis, M. B., pp. 217-218.
  36. Kapis, M. B., p. 218.

 

 
  

Other NEAVS Fact Sheets:
Benefits of Non-Animal Tests | Xenotransplants | Animal Welfare Act | Limitations of Animal Tests | Non-Animal Product Safety Test Alternatives

<< Back to Better Science  | Home

  

NEAVS logo